Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 study evaluating SKY0402 for safety and efficacy in patients undergoing total knee arthroplasty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SKY0402

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Postoperative Pain | Phase 3 | Status: COMPLETED | Results posted: 2013-08-06